α
Stock Quant AI
Research
API
  1. Home
  2. /
  3. Research
  4. /
  5. IBM
IBMHoldEqual Weight

IBM Stock Analysis for February 2026

International Business Machines Corporation

$298.93at time of analysis
1Y Target$285.00-4.7%
3Y Target$340.00+13.7%

Published Saturday, February 7, 2026

1Y Price Target

$285.00

-4.7% vs current price

Technical Setup

RSI 50 / neutral MACD

Support context: $214.50. Resistance context: $324.90.

Valuation Snapshot

P/E 36.98x / P/S ~4.3x (est.)

Market cap $279.4B; revenue ~$65B FY2025 (est.).

Risk Watch

Mainframe Cycle Peak Risk

The z17 mainframe cycle drove 61% growth in IBM Z in Q3 and 21% infrastructure growth in Q4. Mainframe cycles typically peak within 12-18 months of launch, meaning this tailwind will fade and could become a headwind as comparisons get tougher.

Executive Summary

IBM has executed a meaningful transformation over the past several years, pivoting toward software, hybrid cloud, AI, and quantum computing. The Q4 2025 results were genuinely strong — 9% quarterly revenue growth, 14% software growth, 21% infrastructure growth, and a generative AI book of business exceeding $12.5 billion. Annual revenue hit ~$287 billion (note: likely a data error in the transcript; actual FY2025 revenue is closer to $63-65B based on quarterly run rates), with 6% full-year growth. The company guides for >5% constant currency growth in 2026. However, the stock trades at a P/E of ~36-37x on EPS of ~$8.36, which is a rich multiple for a company growing revenue at mid-single digits. While IBM's AI narrative is compelling and the software mix shift is real, the valuation already prices in significant execution. Short interest is minimal at ~2% of float, suggesting no institutional conviction on the downside, but the stock sits only 8% below its 52-week high after a 39% rally from its lows. The risk-reward at current levels is balanced — the transformation is real but largely priced in. I lean slightly bearish on a 1Y basis given the stretched valuation and potential for multiple compression if growth doesn't accelerate further, but see modest upside over 3 years if the software and AI strategy continues to deliver.

Price Targets

1Y Base Target

$285.00-4.7%

3Y Base Target

$340.00+13.7%

1-Year scenario price targets · Dashed line = current price

Scenario Analysis

Scenario1Y Target1Y Growth3Y Target3Y Growth
↑↑Hyper Bull
$380.00+27.1%$500.00+67.3%
↑Bull
$340.00+13.7%$420.00+40.5%
→Neutral
$295.00-1.3%$340.00+13.7%
↓Bear
$245.00-18.0%$260.00-13.0%
↓↓Hyper Bear
$200.00-33.1%$190.00-36.4%
↑↑Hyper Bull
1Y$380
3Y$500
1Y %+27.1%
3Y %+67.3%
↑Bull
1Y$340
3Y$420
1Y %+13.7%
3Y %+40.5%
→Neutral
1Y$295
3Y$340
1Y %-1.3%
3Y %+13.7%
↓Bear
1Y$245
3Y$260
1Y %-18.0%
3Y %-13.0%
↓↓Hyper Bear
1Y$200
3Y$190
1Y %-33.1%
3Y %-36.4%
Hyper Bull: Generative AI enterprise adoption accelerates dramatically, with IBM's watsonx becoming a leading enterprise AI platform. Software growth sustains 12-15% annually, consulting re-accelerates to 8%+, and the market awards IBM a 40-45x P/E as it's re-categorized as a high-growth software company. Quantum computing begins generating meaningful revenue by 2028.
Bull: IBM delivers on its >5% revenue growth guidance for 2026 and sustains mid-to-high single digit growth through 2028. Software continues to outperform, AI book of business converts to recognized revenue at a healthy rate, and margin expansion drives EPS toward $11-12 by 2028. The P/E compresses modestly to 33-35x but earnings growth drives the stock higher.
Neutral: IBM executes reasonably well but the mainframe cycle peaks, consulting growth remains sluggish, and AI revenue growth, while real, doesn't accelerate beyond current trajectory. Revenue grows 4-5% annually, EPS reaches $10 by 2028, but the P/E compresses to 30-32x as the market demands more for the current premium. Total return is modest, supported by the dividend.
Bear: The mainframe cycle peaks and infrastructure revenue declines, consulting faces a downturn amid economic slowdown, and AI spending proves more cyclical than expected. Revenue growth slows to 2-3%, the P/E compresses to 25-28x as the transformation narrative loses credibility, and EPS stagnates around $9-10. The stock gives back much of its 2024-2025 gains.
Hyper Bear: A recession or severe economic slowdown crushes consulting demand, enterprises pull back on AI spending, and the mainframe cycle enters a deep trough. IBM's revenue declines, margins compress, and the market re-rates the stock to 20-22x earnings as it reverts to legacy IBM valuation. The AI narrative collapses as hyperscalers dominate enterprise AI, leaving IBM marginalized.

Key Financial Metrics

Earnings Per Share (EPS)
$8.36
Beta
0.62
Revenue
~$65B FY2025 (est.)
P/E Ratio
36.98x
P/S Ratio
~4.3x (est.)
Market Cap
$279.4B
Net Income
~$7.8B FY2025 (est.)
Dividend Yield
2.2%
Short Interest
1.99% of float (18.61M shares)
52-Week Low
$214.50
52-Week High
$324.90

Technical Overview

Quant overlays derived from the existing 1Y OHLCV series: trend stack, sigma bands, regression fit, drawdown regime, and a composite signal model.

RSI (14)

49.5

Momentum Stack

1M +0.7% / 3M -2.6%

Volatility Regime

45.0% 20D vol

Regression Fit

-2.0% vs trend

Close20D MA50D MA200D MABollinger (20, 2σ)Regression channel centerline

Drawdown Curve

Distance from rolling peak, useful for regime stress and recovery speed.

-5.1%

Trend Regime

neutral

Mixed stack

Composite Signal

neutral

Neutral (+1)

Mean Reversion

neutral

-0.11 sigma

Breakout Status

neutral

Inside channel

Range Percentile

bullish

76th pct

Volume Impulse

bearish

0.69x 20D avg

Quant Dashboard

A compact read on trend persistence, stretch, realized risk, and breakout behavior.

1M Return
+0.7%
6M Return
+19.5%
1Y Return
N/A
ATR (14)
$11.12
20D Vol
45.0%
60D Vol
31.6%
Regression R²
0.56
Price Z-Score
-0.11
52W High
$324.90
52W Low
$214.50
Range Position
76th pct
Latest Volume
3.7M

Micro Analysis

IBM's fundamentals have genuinely improved. Software is now the growth engine, consulting is stabilizing, and the z17 mainframe cycle is providing a cyclical tailwind. However, the P/E of ~37x is historically elevated for IBM and demands continued execution.

Software Segment Momentum

Software revenue grew 14% in Q4 2025 and 9% for the full year, with ARR reaching $23.6 billion. Red Hat and automation are key drivers. OpenShift ARR grew over 30%. This is the highest-quality segment and the core of IBM's re-rating thesis.

Generative AI Business Scale

IBM's generative AI book of business exceeded $12.5 billion, up from $9.5 billion as of Q3. This is a significant growth catalyst, though it's important to note this is a 'book of business' metric (cumulative signings) rather than recognized revenue, which may overstate near-term impact.

Infrastructure Cyclicality

Infrastructure grew 21% in Q4, driven by the z17 mainframe launch. IBM Z revenue surged 61% in Q3. However, mainframe cycles are inherently cyclical — this growth rate will normalize and likely decline as the cycle matures over the next 12-18 months.

Consulting Segment Lagging

Consulting grew only 3% in Q4, the weakest segment. While AI consulting demand is building, the consulting business faces competitive pressure from Accenture, Deloitte, and others. This segment represents a significant portion of revenue and its sluggish growth is a drag.

Valuation Stretched at ~37x P/E

IBM trades at a P/E of ~36-37x on trailing EPS of $8.36. Historically, IBM traded at 12-18x earnings during its legacy period. Even accounting for the software mix shift, this multiple is elevated for a company growing revenue at 5-6% and implies the market has already priced in substantial transformation success.

Free Cash Flow Improvement

IBM expects ~$1 billion year-over-year improvement in free cash flow for 2026. The company's FCF generation supports its dividend (yield ~2.2%) and share repurchases, though the dividend growth rate has been slow and the share count has been rising, diluting per-share metrics.

Macro Analysis

The macro environment is mixed — AI investment is a strong tailwind, but global growth is slowing, trade tensions persist, and there are concerns about stretched tech valuations. IBM's low beta (0.62) provides some defensive characteristics.

AI Capital Expenditure Boom

Enterprise AI spending continues to accelerate, with companies across industries investing in AI infrastructure, software, and consulting. IBM is well-positioned with watsonx, Red Hat, and its consulting capabilities to capture a share of this multi-year spending cycle.

Global Economic Slowdown

The IMF projects global growth slowing to ~2.6% in 2026. U.S. GDP growth is projected at 1.8%. Slower economic growth could constrain enterprise IT budgets, particularly in consulting and discretionary technology spending.

Trade Policy and Tariff Risks

Ongoing tariff uncertainty and geopolitical tensions could impact IBM's global operations across 175 countries. While IBM's software-heavy revenue mix reduces direct tariff exposure, consulting engagements and hardware supply chains remain vulnerable.

Interest Rate and Valuation Environment

If rates remain elevated, high-multiple stocks face compression risk. IBM's ~37x P/E is vulnerable to a rotation away from expensive names, particularly if growth disappoints even modestly.

Competitive Landscape in Cloud and AI

IBM competes against hyperscalers (AWS, Azure, GCP) in cloud and against specialized AI companies. While IBM's hybrid cloud positioning is differentiated, the competitive intensity is fierce and market share gains are hard-won.

Untapped Revenue Opportunities

Generative AI Enterprise Adoption

high

IBM's watsonx platform and consulting capabilities position it to capture enterprise AI demand as companies move from pilot to production deployments. The $12.5B+ book of business suggests strong pipeline conversion potential.

Quantum Computing Commercialization

medium

IBM has generated over $1 billion in quantum computing revenue and Qiskit has 13 million downloads. As quantum computing matures, IBM's early mover advantage in enterprise quantum could become a meaningful revenue stream over 3-5 years.

Red Hat and Hybrid Cloud Expansion

high

Red Hat continues to grow at double-digit rates with OpenShift ARR growing 30%+. The hybrid cloud market is expanding as enterprises adopt multi-cloud strategies, and Red Hat is a critical enabler.

Automation Software Growth

high

Automation software grew 22-24% YoY in recent quarters, driven by enterprise demand for workflow automation and AI-powered process optimization. This is a high-margin, recurring revenue opportunity.

Data Center Migration Services

medium

IBM is positioned as a major player in the data center migration market, which is expanding as enterprises transition to cloud and hybrid environments. This drives both consulting and infrastructure revenue.

Headwinds & Tailwinds

↓ Headwinds

Mainframe Cycle Peak Risk

high

The z17 mainframe cycle drove 61% growth in IBM Z in Q3 and 21% infrastructure growth in Q4. Mainframe cycles typically peak within 12-18 months of launch, meaning this tailwind will fade and could become a headwind as comparisons get tougher.

Valuation Multiple Compression

high

At ~37x trailing P/E, IBM is priced for sustained growth acceleration. Any disappointment in revenue growth, margin expansion, or AI monetization could trigger significant multiple compression back toward 25-30x, implying 15-30% downside.

Consulting Competitive Pressure

medium

IBM's consulting segment faces intense competition from Accenture, Deloitte, and specialized AI consultancies. Growth of only 3% in Q4 suggests market share challenges, and this segment is harder to differentiate.

Share Dilution

medium

IBM's share count has been increasing, diluting EPS growth. While the company generates solid free cash flow, the combination of dividend payments and rising share count limits per-share value creation.

Geopolitical and Trade Risks

medium

Operating in 175 countries exposes IBM to currency fluctuations, trade restrictions, and regulatory complexity. Tariff escalation could impact hardware margins and consulting demand in affected regions.

↑ Tailwinds

Enterprise AI Spending Wave

high

The multi-year enterprise AI adoption cycle is still in early innings. IBM's integrated stack of AI software, consulting, and infrastructure positions it to capture recurring revenue as AI moves from experimentation to production.

Software Mix Shift Improving Margins

high

IBM's deliberate shift toward higher-margin software (now the largest segment) is structurally improving gross margins (54%+) and operating margins. This mix shift supports earnings growth even at moderate revenue growth rates.

Recurring Revenue Base

medium

One-third of IBM's revenue is recurring, with software ARR at $23.6 billion. This provides stability and predictability, reducing downside risk and supporting valuation.

Low Beta Defensive Characteristics

medium

IBM's beta of 0.62 means it tends to outperform in market downturns. With a 2.2% dividend yield and stable cash flows, IBM offers defensive qualities that attract capital during periods of market stress.

Fortune 500 Client Base

medium

IBM serves 95% of Fortune 500 companies, providing deep enterprise relationships that create cross-selling opportunities for AI, cloud, and consulting services. These relationships are sticky and difficult for competitors to displace.

Analysis Summary

Ticker
IBM
Company
International Business Machines Corporation
Analysis Date
2026-02-07
Price at Analysis
$298.93
Rating
Hold
1Y Price Target
$285.00
3Y Price Target
$340.00
Market Cap
$279.4B
P/E Ratio
36.98x

This analysis was generated on 2026-02-07 when IBM was trading at $298.93. The base-case 1-year price target is $285.00 (-4.7% implied return). Scenario range: $200.00 (hyper bear) to $380.00 (hyper bull).

Disclaimer: This report is generated by an AI model and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Past performance is not indicative of future results. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

More Research

CRDOBuy

Credo Technology Group Holding Ltd Ordinary Shares

2026-05-22

GEVHold

GE Vernova Inc.

2026-05-22

VRTHold

Vertiv Holdings Co Class A Common Stock

2026-05-22

Stock Quant AI
SupportNot financial advice.